Invention Grant
US08354243B2 Method for determining presence of cancer in a sample by assaying for expression of ECSA/DPPA-2 nucleotide sequences
失效
通过测定ECSA / DPPA-2核苷酸序列的表达来确定样品中癌症存在的方法
- Patent Title: Method for determining presence of cancer in a sample by assaying for expression of ECSA/DPPA-2 nucleotide sequences
- Patent Title (中): 通过测定ECSA / DPPA-2核苷酸序列的表达来确定样品中癌症存在的方法
-
Application No.: US12310802Application Date: 2007-10-02
-
Publication No.: US08354243B2Publication Date: 2013-01-15
- Inventor: Thomas John , Suzanne Svobodova , Jonathan Cebon , Otavia L. Caballero , Marilyn Monk
- Applicant: Thomas John , Suzanne Svobodova , Jonathan Cebon , Otavia L. Caballero , Marilyn Monk
- Applicant Address: GB London US NY New York
- Assignee: UCL Business plc,Ludwig Institute for Cancer Research
- Current Assignee: UCL Business plc,Ludwig Institute for Cancer Research
- Current Assignee Address: GB London US NY New York
- Agency: Abelman, Frayne & Schwab
- International Application: PCT/US2007/021189 WO 20071002
- International Announcement: WO2008/060370 WO 20080522
- Main IPC: G01N33/574
- IPC: G01N33/574
Abstract:
The invention relates to the discovery of known molecule “DPPA-2” and a so-called “cancer-testis antigen.” DPPA-2 is also a possible cancer stem cell marker. One can determine presence of cancer by assaying for the molecule, and also prevent or treat cancer via administration of the molecule.
Public/Granted literature
Information query
IPC分类:
